Smear negative tuberculosis
Download
1 / 30

Smear-Negative Tuberculosis - PowerPoint PPT Presentation


  • 601 Views
  • Updated On :

Smear-Negative Tuberculosis. Daniel Park, MD, MPH Infectious Diseases Fellow University of California, San Diego. Learning Objectives .

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Smear-Negative Tuberculosis' - DoraAna


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Smear negative tuberculosis l.jpg

Smear-Negative Tuberculosis

Daniel Park, MD, MPH

Infectious Diseases Fellow

University of California, San Diego


Learning objectives l.jpg
Learning Objectives

  • To review the significance of smear negative tuberculosis in HIV-prevalent, resource-constrained settings and diagnostic difficulties and ways to improve diagnosis.

  • To review World Health Organization algorithms for the diagnosis of smear-negative TB and extrapulmonary TB


Introduction l.jpg
Introduction

  • Algorithms developed for the diagnosis of ambulatory, seriously ill, and extrapulmonary tuberculosis

  • Review Algorithms

  • Compare methods of performing sputum microscopy


Background l.jpg
Background

  • Disproportionate increase in rates of smear-negative pulmonary and extrapulmonary tuberculosis in HIV-prevalent and resource-constrained settings

  • Higher mortality in HIV-infected, especially smear negative

    • Over twice the risk of death in Malawi study with 7 years of follow-up data (Kang’ombe CT, et al. Int J Tuberc Lung Dis 2004;8:829-36.)

  • Smear negative status leads to delayed diagnosis and may contribute mortality.

  • Cultures frequently not available

Getahun H, et al. The Lancet; 369:2042 - 2049


Background5 l.jpg
Background

  • Infectivity of smear-negative tuberculosis

    • 22% relative transmission rate compared to smear positive Siddiqi K, et al. Lancet Infect Dis 2003;3:288-296.


Background6 l.jpg
Background

  • Clinical features not sensitive or specific to distinguish TB from non-TB

    • Retrospective multivariate logistic regression analysis

      • 182 patients (~70% HIV) with negative AFB smears; 41 had TB, 141 other diagnosis.

      • Mostly community acquired pneumonia; KS, cryptococcosis, PCP infrequent

    • cough >21 days, chest pain>15 days, absence of expectoration, absence of dyspnea

      • 2 criteria= sensitivity 85%, specificity 67%

      • 3 criteria= sensitivity 49%, specificity 86%

      • adding cervical lymphadenothy increased sensitivity and specificity

        • Samb B, et al. Int J Tuberc Lung Dis 1997;1:25-30


Slide7 l.jpg

Examples of national guide-

lines for the diagnosis of smear

negative TB.

Getahun H, et al. The Lancet; 369:2042 - 2049


Major recommendations l.jpg
Major Recommendations

  • Revised Case Definitions (HIV only)

    • Smear-positive pulmonary tuberculosis only requires one positive smear result.

    • Smear-negative pulmonary TB:

      • At least two sputum exams negative for AFB and

      • X-ray consistent with active TB and

      • Decision by clinician to treat with full course for TB

        • OR

    • AFB smear-negative sputum with cultures that are positive


Case definition l.jpg
Case definition

  • Extrapulmonary Tuberculosis

    • One specimen from an extrapulmonary site culture-positive

      • OR

    • Histological or strong clinical evidence consistent with active extrapulmonary tuberculosis and decision by clinician to treat with full course for TB


Algorithm for the ambulatory hiv positive patient l.jpg
Algorithm for the ambulatory HIV-positive patient

DANGER SIGNS

Respiratory Rate>30/minute

T>39 Celsius

Pulse>120/min

Unable to walk unaided


Algorithm for the ambulatory hiv positive patient12 l.jpg
Algorithm for the ambulatory HIV-positive patient

  • HIV assessment includes HIV clinical staging, CD4 count, referral for HIV care

  • Attempt to get CXR, sputum AFB and culture, clinical assessment all in same visit

    • Likely won’t have results until 3rd visit

  • At least one of the sputum should be early morning

  • Clinical assessment:

    • Evaluating pt with unknown HIV status

    • Assess likelihood of TB and starting empiric therapy

    • Empiric PCP and/or Bacterial therapy


Antibiotics trial l.jpg
Antibiotics Trial

  • Primary role should not be as a diagnostic aid

    • Treat concomitant bacterial infection

    • Common both with and without tuberculosis

    • Non-response increases the likelihood of TB but a response to antibiotics should not exclude TB

    • Antibiotic choice should cover typical causes of community acquired pneumonia but should NOT INCLUDE FLUOROQUINOLONE


Antibiotics trial14 l.jpg
Antibiotics trial

  • Validation of antibiotic algorithm

    • Patients TB suspects

      • respiratory symptoms>3 weeks, abnormal CXR consistent with TB

        OR

      • acute pneumonia and failed outpatient antibiotics

    • Patients with Negative AFB smears treated with amoxicillin x 5 days and erythromycin x 5 days if not improved.

      • 120 patients evaluated

Wilkinson D, et al. 2007. Int J tuberc Lung Dis;4:513-518


Antibiotics trial15 l.jpg
Antibiotics trial

  • “Non-response increases the likelihood of TB”

    PPV 73%

  • “Response to antibiotics should not exclude TB”

    NPV 61%

  • Sensitivity 55%, Specificity 77%


Algorithm for the ambulatory hiv positive patient16 l.jpg
Algorithm for the ambulatory HIV-positive patient

  • 3rd visit will have results of CXR, sputum

    • Decide if likely to have TB

    • If unlikely to have TB based on negative AFB, clinical assessment, CXR

      • PCP and/or bacterial treatment


Algorithm for the ambulatory hiv positive patient17 l.jpg
Algorithm for the ambulatory HIV-positive patient

  • If rapid response to PCP or bacterial treatment must remain vigilant

  • If unsatisfactory response should be re-assessed clinically and bacteriologically for tuberculosis

    • No algorithm provided or further recommendations.


Etiology of pneumonia l.jpg
Etiology of pneumonia

  • Prospective study to evaluate etiology of AFB sputum smear negative pneumonia in HIV-infected patients

    • BAL in 71% and 75% in Senegal and CAR


Algorithm for the seriously ill patient l.jpg
Algorithm for the seriously ill patient

DANGER SIGNS

Respiratory Rate>30/minute

T>39 Celsius

Pulse>120/min

Unable to walk unaided


Algorithm for the seriously ill patient20 l.jpg
Algorithm for the seriously ill patient

  • If immediate referral no possible

    • Finish antibiotic course even if AFB smear positive and start TB treatment

    • If no response to antibiotics in 3-5 days, TB treatment should be initiated and finish initial antibiotic course.

    • Refer to higher level of care if possible to confirm diagnosis of TB and for HIV care.


Improving diagnosis of tb through better smear microscopy l.jpg
Improving diagnosis of TB through better smear microscopy

  • Processing methods:

    • sputum liquefaction

      • by sodium hypochlorite (bleach), NaOH, N-acetyl-L-cysteine-sodium-hydroxide, ammonium sulphate, sodium hydroxide

    • Concentration

      • sedimentation or centrifugation

  • Systemic review: Steingart K. Lancet Infect Dis 2006;6;664-74.

    • bleach and centrifugation increased sensitivity by 18%

    • chemical and overnight sedimentation increased sensitivity by 23% (small number of studies)

    • Could not evaluate HIV-infected given small numbers


  • Extrapulmonary tuberculosis background l.jpg
    Extrapulmonary TuberculosisBackground

    • One in five registered TB patients has extrapulmonary TB

      • Lymph nodes, pleural, disseminated most common

      • Meningeal, pericardial also common

      • Disseminated TB cases one-third of deaths in HIV-positive Africans.

      • Only half of these diagnosed before death.

      • Most patients have no bacteriological or histological confirmation except in lymph node involvement



    Diagnosis of extrapulmonary tb24 l.jpg
    Diagnosis of extrapulmonary TB

    • Maintain high clinical vigilance for ETB

    • Assess clinical response to TB treatment after one month and seek alternative diagnosis if no improvement.

    • ETB is indication for antiretroviral therapy

    • Start co-trimoxazole preventive therapy



    Pleural tb l.jpg

    High mortality (>20%) in first two months of therapy.

    Clotting indicates high protein content and increased likelihood of TB

    >30g/L

    >50% lymphocytes

    If no thoracentesis available, start empiric TB treatment.

    Pleural TB


    Disseminated tb l.jpg

    Clinicians must be vigilant for disseminated TB

    High rates of undiagnosed disseminated TB in febrile, HIV-positive inpatients

    Disseminated TB


    Pericardial effusion l.jpg

    90% of HIV-related pericardial effusions is TB

    50-70% in non-HIV

    Pericardial Effusion


    Tb meningitis l.jpg

    Cryptococcal meningitis is more common than TB in HIV patients

    LP is essential

    Measure opening pressure

    TB Meningitis


    Slide30 l.jpg

    • Samb B, Henzel D, Daley CL, et al. Methods for diagnosing tuberculosis among in-patients in eastern Africa whose sputum smears are negative. Int J Tuberc Lung Dis 1997;1:25-30

    • Wilkinson D, Newman W, Reid A, Squire SB, et al. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis 2000;4:513-518

    • Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. The Lancet 2007; 369:2042 – 2049

    • Steingart KR, Ng V, Henry M, Hopewell PC, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006;6:664-74.

    • World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: Recommendations for HIV-prevalent and resource-constrained settings. Accessed December 5, 2008: www.who.int/entity/tb/publications/2006/tbhiv_recommendations.pdf


    ad